Objectives: Fluoroquinolone resistance (FQR) in third-generation cephalosporin-resistant Enterobacteriaceae (3GCRE) presents serious limitations to antibiotic therapy. The aim of this study was to investigate whether the FQR proportion among 3GCRE differs between community-acquired (CA) and hospital-acquired (HA) isolates.
Introduction
Due to delays in effective therapy, infections with MDR bacteria lead to longer hospital stays and are associated with worsened patient outcomes. Thus, antibiotic resistance is not only a growing healthcare problem, it is also a burden on the economic system. 1, 2 Of great concern is the emergence of ESBL-producing Enterobacteriaceae because ESBL mediates resistance to penicillin and cephalosporins including ceftriaxone and most other third-generation cephalosporins (3GC). 3 These 3GC-resistant (3GCR) Enterobacteriaceae (3GCRE) are often also resistant to fluoroquinolones (and aminoglycosides). This combined resistance phenotype represents a major limitation in therapeutic options, making carbapenems the drugs of choice in many cases. In Europe, 4.3% of the Escherichia coli isolates detected in blood or cerebrospinal fluid showed this MDR pattern. 4 In Germany the proportion appears to be higher: 5.4% of the E. coli and 7.1% of the Klebsiella pneumoniae isolates from ambulatory care and 8.9% of the E. coli and 10.2% of the K. pneumoniae isolates from the hospital care sector exhibited this pattern. 5 The goal of the present study was to investigate potential differences in fluoroquinolone resistance (FQR) between hospitalacquired (HA) and community-acquired (CA) 3GCRE.
Methods

Study design and data sources
This study is a secondary analysis of a prospective observational study in the ATHOS (Antibiotic Therapy Optimization Study) project. Hospitalized patients were monitored for the first 3GCRE occurrence in six German university hospitals in 2014 and 2015. Adult patients admitted to acute care services other than psychiatry, dermatology, otorhinolaryngology, ophthalmology, paediatrics and gynaecology were included. 6 Isolates with non-susceptibility to ciprofloxacin were counted as FQR. Isolates detected in specimens taken on days 1-3 (admission day " day 1) were considered to be CA, whereas those detected from day 4 onwards were considered to be HA. 7 Isolates detected in specimens that suggest an impact on patient health, like wound swabs, blood, urine etc., were considered clinically relevant. Infections were defined as detection in clinically relevant specimens with signs of clinical infection and therapeutic intervention.
Statistical analysis 
Ethics and data protection
Surveillance was performed in accordance with the German Infection Protection Act. 8 The data were entered into an online accessible database 
Results
The study included 578 420 admissions over the 2-year period and yielded 5721 clinically relevant 3GCRE isolates. Of these, 3145 (55.0%) were isolated from male patients, 2623 (45.8%) were E. coli, 906 (15.8%) were Klebsiella spp. and approximately half of all isolates were HA 3GCRE (3026; 52.9%). The overall FQR proportion among 3GCRE was 52.7% (n " 3017) ( Table 1) , ranging between 33.2% and 70.5% from the participating hospitals. CA 3GCRE had a significantly higher proportion of FQR than HA 3GCRE (60.1% versus 46.2%, respectively).
Stepwise backward and stepwise forward variable selection yielded the same multivariable model that included age, gender, E. coli, Klebsiella spp. and community acquisition as independent factors for FQR detection in 3GCRE (Table 2) . CA 3GCRE showed a higher risk of FQR than HA 3GCRE (CA: aRR 1.33, 95% CI 1.17-1.53). E. coli and Klebsiella spp. showed a very high and significant risk for FQR (aRR 8.14 and 7.62, respectively) compared with other Enterobacteriaceae species. Being female was found to be protective (aRR 0.77, 95% CI 0.72-0.83) and age was not associated with FQR. The infection status (infection versus colonization), ward category and service type were not associated with FQR in the multivariable model.
Discussion
The somewhat surprising higher FQR proportion in CA 3GCRE was observed among E. coli, Klebsiella spp. and other Enterobacteriaceae. We think the reasons for these findings are manifold. The data essentially indicate a substantial selection pressure from fluoroquinolones outside the hospital coming from antibiotic consumption in patients and probably in their environment and in food production.
Patients with isolation of a 3GCRE strain on admission or within two days after the admission day likely represent a group with relevant and perhaps repeated exposures to antibiotics because of infection risks associated with underlying diseases. We excluded MDR screening specimens but clinically relevant cultures may have been ordered intensely in this period. Outpatient management of these patients may have often included oral antibiotics with enhanced coverage for Gram-negative bacteria, and in many cases these drugs will be broad-spectrum cephalosporins or fluoroquinolones rather than amoxicillin or trimethoprim/sulfamethoxazole. Fluoroquinolone use in the month prior to hospital admission was found to be associated with detection of FQR E. coli in the first three days of hospital stay. 9 Unfortunately, our dataset does not include patient-based antibiotic consumption data. Interestingly, surveillance data on outpatient antibiotic consumption show enhanced use of oral cephalosporins in Germany compared with other European countries. Fluoroquinolone consumption is comparable with the population-weighted EU mean. 10 However, more fluoroquinolones are prescribed in ambulatory compared with hospital care (total of 21.2 versus 9.3 million DDDs, respectively). [11] [12] [13] A similar relationship was found in England.
14 Excessive fluoroquinolone use in ambulatory care may explain the higher FQR proportion observed in CA 3GCRE. E. coli and Klebsiella spp. were found to have an increased risk of being FQR. In infections with both species, in addition to fluoroquinolone use, aminoglycoside use was shown to be an independent risk factor for FQR occurrence in 3GCRE. 15 Such co-selection processes would not be expected to be relevant in newly admitted patients and are less likely to explain the high FQR proportion in our dataset.
This study is the first to compare FQR in CA and HA 3GCRE. Limitations may be the definition of community acquisition including two days after the admission day, which may have been too broad, and ignoring previous admissions, outpatient treatments or travel history. Also, we did not include cephalosporin-susceptible Enterobacteriaceae and therefore cannot distinguish whether the increased FQR proportion among CA 3GCRE is specific for 3GCRE or a general phenomenon. Moreover, the database included only initial detections of 3GCRE. Missing follow-up data may lead to an underestimation of HA 3GCRE with and without FQR. In addition, frequent carbapenem use in hospital patients for suspected MDR pathogens may suppress or even eliminate colonizing MDR Gramnegative bacteria which may result in fewer detections of FQR 3GCRE. As the microbiological data of the isolates were generated by hospital routine diagnostics, 3GCR mechanism data are not available. From a parallel admission prevalence study we know that the majority of 3GCR in the endogenous bacteria of our patients was caused by ESBL (67% CTX-M1 group and 17% CTX-M9 group) and about 10% was caused by AmpC genotypes. 16 We still consider the finding that community acquisition rather than hospital acquisition of 3GCRE is associated with FQR significant and important. It confirms the need for more data from and antibiotic stewardship activities in the outpatient setting. General practitioner-based surveillance modules informing them about their antibiotic prescription behaviour and dedicated antibiotic stewardship (ABS) programmes may increase adherence to prescription guidelines. 17 Voluntary (group) education for practitioners has been shown to reduce inappropriate antibiotic prescriptions. 18 In addition, non-prescribed use of antibiotics is of concern. In representative surveys, about 5%-8% of the German Rohde et al.
participants reported antibiotic usage that had not been prescribed (EU mean, 7%). 19, 20 Educating the population on the development of antibiotic resistance, restricting use to prescription antibiotics worldwide and removing antibiotics from online pharmacy portfolios may sustain their therapeutic effectiveness.
